Novo Integrated (NVOS) - Market Cap to Earnings

Novo Integrated - graphic logo of issuer NVOS

Novo Integrated Sciences (NVOS) is combating the attrition of entry-level staff by focusing on hiring compliance experts while maintaining stable leadership. The business is surviving under intense pressure from insurance corporations and large networks. This chart illustrates the asset's market value fixed at -0.10. The company's efficiency is sustained through the strategic distribution of wellness products and tight inventory control to protect profits.

Novo Integrated Sciences Corp - NVOS Price to Earnings Ratio (period 07/04/2022 - 11/09/2024)

Analytical breakdowns for Novo Integrated Sciences

- market capitalization indicators:
General company analysis:Novo Integrated Sciences Inc
Product sample of Novo Integrated Sciences, Inc.

The P/E ratio reflects the investment payback period through the relationship between market capitalization and net income. Analyzing the historical average P/E of Novo Integrated Sciences (NVOS) allows for the identification of whether the asset is overvalued or if its potential is undervalued. For Novo Integrated Sciences (NVOS), this balance is critical when scaling its clinic network and implementing AI diagnostics. This metric demonstrates the extent to which the market is willing to award a premium for the business's technological transformation. The stability of this ratio confirms the resilience of the healthcare ecosystem.

Analysis of competing companies

Market Cap to Earnings hcahealthcare.com HCA|Price to Earnings Ratio Tenet Healthcare (THC)|Fresenius Medical Care - Price to Earnings Multiple|Price to Earnings Ratio Solventum SOLV|Market Price to Net Income Ratio EHC (Encompass Health)|UHS: Price to Earnings Ratio|DVA (DaVita) - Price to Earnings Multiple|RadNet Corp (RDNT) - Price to Earnings Ratio|Market Cap to Earnings Option Care Corp (OPCH)|Price to Earnings Ratio SGRY|PINC: Company Value to Net Income|P/E Multiple EYE|PGNY - Market Cap to Earnings|P/E Multiple ARDT (ardenthealth.com)|SEM - Price to Earnings Ratio|Astrana Corp - P/E Multiple|Company Value to Net Income MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Price to Earnings Ratio|Market Cap to Earnings Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - P/E Multiple|NUTX: Company Value to Net Income|P/E Multiple AUNA|Price to Earnings Ratio SBC Medical Group Holdings Inc SBC|Price to Earnings Ratio Jeuveau EOLS|Company Value to Net Income CYH|SKIN: Price to Earnings Ratio|Company Value to Net Income MDWD (MediWound)|BTMD (biote.com) - Price to Earnings Ratio|Price to Earnings Ratio thejoint.com|DCGO (DocGo, Inc.) - P/E Multiple|Price to Earnings Ratio PIII|Price to Earnings Ratio GANX (Gain Therapeutics Inc.)|P/E Multiple EUDA Health (EUDA)|Basel Medical Group - Price to Earnings Ratio|Market Price to Net Income Ratio CLGN (CollPlant Ltd)|cuprina.com.sg - P/E Multiple|Company Value to Net Income CCM (Concord Medical Services Holdings)|AMS: P/E Multiple|Market Cap to Earnings MEDIROM Corp (MRM)|ALBT (Avalon GloboCare Corporation) - P/E Multiple|Price to Earnings Multiple DHAI (DIH Holding US, Inc.)|P/E Multiple XAGE|Business Payback Period NewGenIvf Group|Price to Earnings Ratio ATI Physical Therapy Inc. ATIP|CareMax Medical Group (CMAX) - Market Cap to Earnings|KDLY - Price to Earnings Ratio|Company Value to Net Income MODV (ModivCare Inc.)|SunLink Health Systems (SSY) - Price to Earnings Ratio|Price to Earnings Ratio IMAC Holdings Inc